TP53 and colorectal carcinoma: To get a first assessment of resveratrol’s anti-CRC effect in a p53-dependent manner, resveratrol’s concentration-dependent (0, 1, 5, 10, 20, 40μM) impact on HCT-116 WT or HCT-116 p53-/- cells in 3D alginate beads was compared by MTT viability test.